Automated description from the Alliance of Genome Resources (Release 3.1.1)
Predicted to have serine-type endopeptidase inhibitor activity. Predicted to be involved in negative regulation of endopeptidase activity. Predicted to localize to extracellular space. Is expressed in several structures, including esophagus; liver lobe; oral epithelium; and skin. Orthologous to human SERPINB10 (serpin family B member 10).